Alzheimer’s research is at the forefront of neurological science, exploring the complexities of this devastating condition that affects millions.Recent advances have illuminated the critical role of microglial cells, the brain’s immune system, in maintaining healthy neural pathways.
TIM-3 therapy for Alzheimer’s is emerging as a promising avenue in the battle against this debilitating disease.Recent studies have shed light on the role of this immune checkpoint molecule, suggesting that its inhibition could liberate microglia— the brain’s immune cells—allowing them to effectively remove amyloid plaques that are notorious for disrupting cognitive function.